Vivimed Labs on Monday received approval for 2 products from Uzbekistan Government for its PICS & Health Canada approved site, both facilities are situated in Hyderabad.
Drug firm Vivimed Labs NSE 3.16 % on Monday said it has received approval from the Uzbekistan government for two products.
Vivimed Labs Limited, a niche Specialty Chemicals and Pharmaceuticals company, announced today that it received approvals for 3 ophthalmic products from its state of the art sterile Ophthalmic facility and 3 oral liquid suspension products from its PICS & Health Canada approved site, both facilities are situated at Hyderabad
Vivimed Labs Limited, a niche specialty chemicals and pharmaceuticals company, has received export order for supply of Favulous tablets 200 mg.
Vivimed`s Uquifa expects Euro 200 mn revenues in 4 yrs
Vivimed Life Sciences Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP
Vivimed arm Uquifa bets on CDMO
Vivimed Global's Generic Ranitidine Hydrochloride Receives Approval in US
Vivimed arm Uquifa eyes € 200 mn revenue